Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain – results of the LEARN Study

Daily granulocyte colony-stimulating factors [(G-CSFs); e.g. filgrastim, lenograstim] are frequently used to reduce the duration of chemotherapy-induced neutropenia (CIN) and the incidence of febrile neutropenia (FN) in cancer patients. A pegylated formulation of filgrastim, pegfilgrastim, which is...

Descripción completa

Detalles Bibliográficos
Autores principales: ALMENAR, D, MAYANS, J, JUAN, O, BUENO, JM GARCIA, LOPEZ, JI JALON, FRAU, A, GUINOT, M, CEREZUELA, P, BUSCALLA, E GARCIA, GASQUET, JA, SANCHEZ, J
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702003/
https://www.ncbi.nlm.nih.gov/pubmed/19076208
http://dx.doi.org/10.1111/j.1365-2354.2008.00959.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702003/
https://www.ncbi.nlm.nih.gov/pubmed/19076208
http://dx.doi.org/10.1111/j.1365-2354.2008.00959.x

Ejemplares similares